VC

Venkata Chalapathirao Gurramkonda

Active Director Director DIN 11001141
DIN 11001141 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Chalapathirao Gurramkonda

Data last updated:

Venkata Chalapathirao Gurramkonda is a Director at Transcis Ai Private Limited (since 2025). The company operates in Healthcare.

DIN 11001141
Primary Designation Director
Industry Healthcare
First Appointment 07 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Transcis Ai Private Limited U46596UP2025PTC220735
Director07 Apr 20252025Active

Board colleagues of Venkata Chalapathirao Gurramkonda

NameDINCompanyDesignation
Bimla10918991Transcis Ai Private LimitedDirector

Directorship timeline

Open interactive timeline →
Transcis Ai Private Limited
Premium access

Shareholding and investment profile for Venkata Chalapathirao Gurramkonda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Chalapathirao Gurramkonda

Venkata Chalapathirao Gurramkonda currently holds 1 directorship: Transcis Ai Private Limited (Director, since 07 Apr 2025).

Venkata Chalapathirao Gurramkonda was first appointed on 07 Apr 2025 as Director at Transcis Ai Private Limited.

The current boards of Venkata Chalapathirao Gurramkonda's companies include Bimla (Transcis Ai Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available